Cancer News and Research

Latest Cancer News and Research

Brain tumors hijack healthy neurons in order to grow

Scientists have discovered that brain tumors integrate themselves with the brain’s healthy neuronal network to support their growth.

19 Sep 2019

New protein could offer a fresh target for cancer treatment

A study has revealed a drug target called the mitoNEET cell protein, which determines how materials are transported from the mitochondria to the rest of the cell.

19 Sep 2019

Researchers discover how cancer cells can trigger chronic muscle wasting condition

A solid tumor can cause muscle cells in the body to self-destruct. Many cancer patients die from the consequences. Now researchers are discovering more about how cancer cells in a tumor can take control of muscle cell wasting and trigger a chronic, serious condition.

19 Sep 2019

DNA origami: creating DNA-based nanomachines

DNA-based nanomachines are being created by DNA origami in several ways to create mechanical force at the scale of picoNewtons.

19 Sep 2019

Promising new target regulating mitochondria during stress identified

Like an emergency response team that is called into action to save lives, stress response proteins in the heart are activated during a heart attack to help prevent cell death.

19 Sep 2019

Texas leads in worksite lactation support initiatives, research shows

Texas is ranked in the top quarter of the U.S. for its worksite lactation support initiatives, according to research led by The University of Texas Health Science Center at Houston School of Public Health.

19 Sep 2019

Diarrhea linked significantly to weight gain

A study has shown that obesity is linked to chronic diarrhea, independent of other lifestyle or eating habits.

19 Sep 2019

Study uncovers new factor in the development of childhood lymphoma

A study recently published in the renowned journal Blood, led by Kaan Boztug, Scientific Director of the St. Anna Children's Cancer Research Institute, the Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases, Adjunct Principal Investigator at the CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences and Associate Professor at the Medical University of Vienna, together with scientists from Israel, Germany, Turkey, Colombia, Argentina and the USA, investigated four patients from independent families with malignancy, autoimmunity and immunodeficiency.

19 Sep 2019

TUM researchers identify complex interactions between bacteria and parasites

A team at the Technical University of Munich has completed the first study of the effects of a simultaneous infection with blood flukes (schistosomes) and the bacterium Helicobacter pylori - a fairly common occurrence in some parts of the world.

19 Sep 2019

Low-dose aspirin may improve survival in patients with head and neck, lung cancers

What if a drug that sits in nearly everyone's medicine cabinet could help extend the lives of some cancer patients? In companion presentations at the American Society for Therapeutic Radiation Oncology Annual Meeting in Chicago, doctors from Roswell Park Comprehensive Cancer Center report new evidence that low-dose aspirin and other anti-inflammatories may improve survival in patients undergoing treatment for some head/neck and lung cancers.

19 Sep 2019

Mercy's Hoffberger Breast Center offers new device to make lymphedema screening quick and easy

The Hoffberger Breast Center at Mercy Medical Center now offers patient a new device designed to make screening for lymphedema-- a common side-effect following breast cancer surgery -- quick and easy.

19 Sep 2019

Using 3D virtual reality models to prepare for surgeries improves patient outcomes

A UCLA-led study has found that using three-dimensional virtual reality models to prepare for kidney tumor surgeries resulted in substantial improvements, including shorter operating times, less blood loss during surgery and a shorter stay in the hospital afterward.

19 Sep 2019

Microrna-based therapy may prove to be effective against chemotherapy-resistant cancers

A technology that manipulates microRNAs developed by Jingfang Ju, PhD, a biochemist and Professor in the Department of Pathology at the Renaissance School of Medicine at Stony Brook University, and colleagues has shown promise when used as anti-cancer therapeutic.

19 Sep 2019

Nearly half of NCI-sponsored trials on clinical cancer were associated with new drug approvals

A new study shows that nearly half of phase 3 cancer clinical trials carried out by the National Cancer Institute (NCI)-sponsored SWOG Cancer Research Network, one of five groups in NCI's National Clinical Trials Network (NCTN), were associated with clinical care guidelines or new drug approvals. NCI is part of the National Institutes of Health.

19 Sep 2019

Study opens a promising new front in the fight against pancreatic cancer

Pancreatic adenocarcinoma (PDAC) is a lethal malignancy that most often is resistant to chemotherapy. Researchers have been searching for ways to increase the sensitivity of the tumors to cancer-fighting drugs.

19 Sep 2019

NMDAR receptor is responsible for breast-to-brain metastases, shows study

In 2018, breast cancer was the most common cancer in women worldwide, accounting for about a quarter of all reported cancers. One of the biggest problems with any type of cancer is metastasis; and when breast cancer metastasizes, the brain is a common destination.

19 Sep 2019

Mint-flavored vapes and the trouble with pulegone

Even while the recent outbreak of acute serious lung disease in vapers is challenging the skill and technology of the medical field, a new report published in the journal JAMA Internal Medicine on September 16, 2019, says that a natural plant oil called pulegone, which is used to impart a minty flavor to e-cigarettes, could quite possibly be carcinogenic at the levels found in these devices.

18 Sep 2019

New device uses electromagnetic waves to reverse Alzheimer’s

A new study, to be published in the September 3, 2019, issue of the Journal of Alzheimer's Disease, provides something to cheer about for the estimated 44 million patients who have Alzheimer’s disease (AD) in the US, and their hard-pressed caregivers.

18 Sep 2019

Roswell Park moving three-pronged immunotherapy strategy forward with support from DoD grant

A team from Roswell Park Comprehensive Cancer Center is moving a new three-part strategy for treating advanced cancers forward with support from a U.S. Department of Defense grant to Pawel Kalinski, MD, PhD, Vice Chair for Translational Research and Rustum Family Professor for Molecular Therapeutics and Translational Research at the Buffalo, N.Y.-based cancer center.

18 Sep 2019

NUS chemists develop new anti-cancer drug with less renal toxicity

A team of pharmacists and chemists from the National University of Singapore has developed a new anti-cancer drug that has less toxic effects to the kidneys.

18 Sep 2019

Cancer News and Research

Latest Cancer News and Research

Brain tumors hijack healthy neurons in order to grow

New protein could offer a fresh target for cancer treatment

Researchers discover how cancer cells can trigger chronic muscle wasting condition

DNA origami: creating DNA-based nanomachines

Promising new target regulating mitochondria during stress identified

Texas leads in worksite lactation support initiatives, research shows

Diarrhea linked significantly to weight gain

Study uncovers new factor in the development of childhood lymphoma

TUM researchers identify complex interactions between bacteria and parasites

Low-dose aspirin may improve survival in patients with head and neck, lung cancers

Mercy's Hoffberger Breast Center offers new device to make lymphedema screening quick and easy

Using 3D virtual reality models to prepare for surgeries improves patient outcomes

Microrna-based therapy may prove to be effective against chemotherapy-resistant cancers

Nearly half of NCI-sponsored trials on clinical cancer were associated with new drug approvals

Study opens a promising new front in the fight against pancreatic cancer

NMDAR receptor is responsible for breast-to-brain metastases, shows study

Mint-flavored vapes and the trouble with pulegone

New device uses electromagnetic waves to reverse Alzheimer’s

Roswell Park moving three-pronged immunotherapy strategy forward with support from DoD grant

NUS chemists develop new anti-cancer drug with less renal toxicity

Understanding the DNA Damage Response in Innate Immunity eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in